COVID-19
Avacta’s lateral flow test can detect Delta variant
June 29, 2021Manufacturing and Production Avacta, COVID-19, Delta variant, antigen lateral flow test
A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …
Tapeworm drug to be trialled nationally as COVID treatment
June 25, 2021Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm
Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …
Survey reveals over 2 million people impacted by long COVID in UK
June 24, 2021COVID-19, UK, government, long covid, study
A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …
Australia pauses AstraZeneca vaccine for people under 60
June 18, 2021Medical Communications AstraZeneca, Australia, COVID-19, Vaccine
Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …
UK COVID vaccine update
June 16, 2021Research and Development COVID-19, UK, care homes, children, government, vaccines
Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
Ground-breaking COVID antibody treatment proven to save lives
June 16, 2021Research and Development COVID-19, UK, antibodies, trial
Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …
AstraZeneca antibody fails to prevent COVID in exposed patients
June 15, 2021Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial
AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …
Experimental COVID antibody treatment successful in trials
June 14, 2021Sales and Marketing COVID-19, antibody therapy, celltrion, phase III
Celltrion has announced positive top-line data for its experimental antibody COVID-19 treatment, with Phase III trials finding it safe and …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
Pfizer to expand COVID vaccine study in children under 12
June 10, 2021COVID-19, Pfizer, Vaccine
Pfizer has announced that it will begin large-scale testing of its COVID-19 vaccine after selecting a lower dose of the …
MHRA confirms registration of Avacta’s lateral flow test
June 7, 2021Sales and Marketing COVID-19, EU, MHRA, lateral flow test
Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …
Vaccine patch outperforms needle-and-syringe jabs in pre-clinical study
June 3, 2021COVID-19, Vaccine, technology
Vaxxas, an Australian clinical-stage biotechnology company, has announced positive results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) …
Moderna submits BLA with FDA for COVID vaccine
June 2, 2021Research and Development COVID-19, EU, FDA, Lonza, Moderna, production
Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …
First COVID-fighting herbal supplement launched
May 27, 2021COVID-19, herbal supplement
The first herbal supplement shown in clinical trials to prevent COVID-19 symptoms from deteriorating has been launched by Swiss Pharmacan …
Japan approves Moderna & AstraZeneca COVID-19 vaccines
May 21, 2021Medical Communications COVID-19, Japan, Vaccine
A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
